Vor Bio Revenue and Competitors
Estimated Revenue & Valuation
- Vor Bio's estimated annual revenue is currently $34.6M per year.
- Vor Bio's estimated revenue per employee is $155,000
Employee Data
- Vor Bio has 223 Employees.
- Vor Bio grew their employee count by 40% last year.
Vor Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Regulatory Officer | Reveal Email/Phone |
3 | Chief Scientific Officer and Head Technical Operations | Reveal Email/Phone |
4 | Chief Commercial Officer (CCO), Head Business Development | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Chief People Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | VP, Regulatory Affairs | Reveal Email/Phone |
Vor Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Vor Bio?
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
keywords:N/AN/A
Total Funding
223
Number of Employees
$34.6M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.6M | 223 | -55% | N/A |
#2 | $66.2M | 223 | 1% | N/A |
#3 | $51.7M | 224 | 2% | N/A |
#4 | $44.6M | 225 | 16% | N/A |
#5 | $34.7M | 225 | 20% | N/A |